Sugar-sweetened Beverage Intake Associations with Fasting Glucose and Insulin Concentrations Are Not Modified by Selected Genetic Variants in a ChREBP-FGF21 Pathway: a Meta-Analysis
Nicola M. McKeown,Hassan S. Dashti,Jiantao Ma,Danielle E. Haslam,Jessica C. Kiefte-de Jong,Caren E. Smith,Toshiko Tanaka,Mariaelisa Graff,Rozenn N. Lemaitre,Denis Rybin,Emily Sonestedt,Alexis C. Frazier-Wood,Dennis O. Mook-Kanamori,Yanping Li,Carol A. Wang,Elisabeth T. M. Leermakers,Vera Mikkilä,Kristin L. Young,Kenneth J. Mukamal,L. Adrienne Cupples,Christina-Alexandra Schulz,Tzu-An Chen,Ruifang Li-Gao,Tao Huang,Wendy H. Oddy,Olli Raitakari,Kenneth Rice,James B. Meigs,Ulrika Ericson,Lyn M. Steffen,Frits R. Rosendaal,Albert Hofman,Mika Kähönen,Bruce M. Psaty,Louise Brunkwall,Andre G. Uitterlinden,Jorma Viikari,David S. Siscovick,Ilkka Seppälä,Kari E. North,Dariush Mozaffarian,Josée Dupuis,Marju Orho-Melander,Stephen S. Rich,Renée de Mutsert,Lu Qi,Craig E. Pennell,Oscar H. Franco,Terho Lehtimäki,Mark A. Herman
DOI: https://doi.org/10.1007/s00125-017-4475-0
2018-01-01
Abstract:Sugar-sweetened beverages (SSBs) are a major dietary contributor to fructose intake. A molecular pathway involving the carbohydrate responsive element-binding protein (ChREBP) and the metabolic hormone fibroblast growth factor 21 (FGF21) may influence sugar metabolism and, thereby, contribute to fructose-induced metabolic disease. We hypothesise that common variants in 11 genes involved in fructose metabolism and the ChREBP-FGF21 pathway may interact with SSB intake to exacerbate positive associations between higher SSB intake and glycaemic traits.